Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05HRK
|
||||
| Former ID |
DNC011259
|
||||
| Drug Name |
2-Hexadecynoic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531170] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H28O2
|
||||
| Canonical SMILES |
CCCCCCCCCCCCCC#CC(=O)O
|
||||
| InChI |
1S/C16H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-13H2,1H3,(H,17,18)
|
||||
| InChIKey |
MECFGCCEVOFCNS-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-hydroxyacyl-acp dehydratase | Target Info | Inhibitor | [531170] | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Target Info | Inhibitor | [531170] | ||
| Fatty acid synthase | Target Info | Inhibitor | [531170] | ||
| 3-oxoacyl-[acyl-carrier protein] reductase | Target Info | Inhibitor | [531170] | ||
| Pathway Interaction Database | p73 transcription factor network | ||||
| Validated transcriptional targets of deltaNp63 isoforms | |||||
| PathWhiz Pathway | Fatty Acid Biosynthesis | ||||
| WikiPathways | Fatty Acid Biosynthesis | ||||
| Nuclear Receptors Meta-Pathway | |||||
| Liver X Receptor Pathway | |||||
| Activation of Gene Expression by SREBP (SREBF) | |||||
| SREBF and miR33 in cholesterol and lipid homeostasis | |||||
| SREBP signalling | |||||
| Metabolism of water-soluble vitamins and cofactors | |||||
| Integration of energy metabolism | |||||
| Fatty acid, triacylglycerol, and ketone body metabolism | |||||
| AMPK Signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.